Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lantern Pharma Inc. - Common Stock
(NQ:
LTRN
)
3.030
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lantern Pharma Inc. - Common Stock
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 13, 2025
Via
Benzinga
Lantern Pharma Earnings Preview
↗
November 12, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
September 30, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 14, 2025
Via
Benzinga
Lantern Pharma's Earnings Outlook
↗
May 14, 2025
Via
Benzinga
Preview: Lantern Pharma's Earnings
↗
March 26, 2025
Via
Benzinga
Recap: Lantern Pharma Q4 Earnings
↗
March 18, 2024
Via
Benzinga
Lantern Pharma Narrows Loss in Q2
↗
August 13, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 16, 2025
Via
Benzinga
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
↗
May 12, 2025
Lantern Pharma receives FDA clearance to begin Phase 1b/2 trial of LP-184 in advanced NSCLC patients with key mutations and low PD-L1 expression.
Via
Benzinga
EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial
↗
May 05, 2025
Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations.
Via
Benzinga
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
Earnings Scheduled For March 27, 2025
↗
March 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 13, 2024
Via
Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q2 2024
↗
August 08, 2024
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 10, 2024
Via
Benzinga
LTRN Stock Earnings: Lantern Pharma Misses EPS for Q1 2024
↗
May 09, 2024
LTRN stock results show that Lantern Pharma missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire
↗
May 01, 2024
Keep an eye on machine learning stocks. With big demand, we could be looking at a half-trillion-dollar market by 2030.
Via
InvestorPlace
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
↗
April 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 11, 2024
Via
Benzinga
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
↗
March 31, 2024
No AI category went down in February, but 3 did in March - confirming my comment last week that
Via
Talk Markets
Topics
Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
↗
March 23, 2024
All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial...
Via
Talk Markets
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
March 19, 2024
Via
Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023
↗
March 18, 2024
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 18, 2024
↗
March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
